Navigation Links
Cheetah Medical's NICOM Non-Invasive Cardiac Output Monitor Featured in a Presentation at the Heart Failure Society of America (HFSA) Annual Meeting
Date:9/19/2007

Study Showed That NICOM can be Used to Accurately Measure Cardiac Output

During Cardiopulmonary Exercise Testing (CPX)

WASHINGTON, September 19 /PRNewswire/ -- Cheetah Medical Inc., developers of the Cheetah NICOM(TM) system, for non-invasive, real-time cardiac output monitoring, announced at HFSA the results of the study "Markers of ventilatory inefficiency in heart failure are related to peak exercise."

The study, led by Dr. Jon Myers of Stanford University and the VA Palo Alto Health Care System, used the NICOM to measure the cardiac output of 36 patients. Results showed that the NICOM accurately measured cardiac output. This is the first time that the NICOM was used in a study during cardiopulmonary exercise on heart failure patients.

Dr. Myers concluded, "NICOM provided accurate measurements of cardiac output and thoracic fluid during cardiopulmonary exercise. The possibility of using a non-invasive, accurate tool to measure cardiac output may provide clinicians with an important diagnostic tool that can contribute to optimization of CHF treatment and provide an early indication of disease escalation."

The NICOM(TM) Cardiac Output Monitor, developed by Cheetah Medical, is a portable system that utilizes the proprietary BIOREACTANCE(TM) technology to measure cardiac output in virtually any clinical setting. Cheetah considers BIOREACTANCE to be a superior modality to measure cardiac output, especially in clinical settings where continuous monitoring of cardiac output is imperative, and in clinical environments such as intensive care units, emergency departments and during stress tests, where there is significant electrical noise and patient movement.

Cheetah's BIOREACTANCE(TM) technology has been validated in the United States and Europe on hundreds of hemodynamically challenged patients in a variety of clinical settings, in the presence of significant environmental factors.

Laura Rector, General Manager of Cheetah Medical in the United States stated, "This study is important because, until the NICOM System, there has not been a technology as practical and simple, that is available to clinicians to accurately and easily provide exercise cardiac output. The NICOM System is a robust diagnostic tool for measuring cardiac output. The patented BIOREACTANCE technology opens opportunities for clinicians to improve patient care based on real-time accurate cardiac output measurements."

Ms. Rector continued, "We have now established our US Sales and Marketing Organization and we are excited about starting sales in the US Market. Based on the initial market reaction, there is clearly a great, untapped need for Cheetah's unique and proprietary technology."

About the BIOREACTANCE(TM) Technology

The Cheetah family of NICOM Cardiac Output Monitors implements the unique and proprietary BIOREACTANCE(TM) technology. BIOREACTANCE is a novel technology platform which analyzes changes in amplitude as well as frequency of electrical impulses as they traverse the chest. These changes are analyzed by software programming to provide a continuous, highly accurate and stable, non-invasive measurement of cardiac output and other cardiac parameters.

About the Company

Cheetah Medical is based in Tel Aviv, Israel and Indianapolis, Indiana. The company is establishing NICOM(TM) as a frontline tool to monitor cardiac function in inpatient and outpatient areas of high unmet need. Importantly, this unique and proprietary technology has been proven to provide accurate and reliable measurements of cardiac output, even during patient movement and across a variety of body types. These features enable the device to be used in several important clinical applications, including intensive care, anesthesia and peri-operative settings, step down, emergency room, dialysis clinic, cardiac care unit, ECO(TM) (Exercise CO testing), CRT-pacemaker optimization, thoracic fluid content (TFC) for acute and chronic heart failure management, home Holter monitoring of cardiac rhythm, thoracic fluid content and cardiac function together, and out-patient heart failure diagnosis/ monitoring.

For more information please visit http://www.cheetah-medical.com or e-mail, cheetah@cheetah-medical.com.

Contact: Laura Rector

+1-317-603-1822


'/>"/>
SOURCE Cheetah Medical Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. GE Medicals Technologies Aid Battle Against Cancer
2. GE Medicals Acquisitions May Prompt More Purchases
3. DGGE Analysis for Non-Invasive Studies of Primate Diet
4. Radiology advance points way to non-invasive brain-cancer treatment
5. Criticare gets OK to market portable cardiac monitor
6. Versatile Reporter Vectors for Monitoring Viral Transduction
7. Cis-Reporting System Monitors Intracellular Calcium Mobilization
8. Cis-Reporting System Monitors Intracellular Calcium Mobilization
9. Monitoring transfection efficiency by green fluorescent protein (GFP) detection with the Agilent 2100 bioanalyzer
10. Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System
11. Monitoring Bacterial Genetic Diversity in a Freshwater Lake Using TTGE and DNA Sequence Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... York , May 4, 2016 ... Transparency Market Research "Metabolomics Market - Global Industry Analysis, ... the metabolomics market is anticipated to expand at a ... USD 2,494.8 million by 2024. Metabolomics is ... metabolites, within cells, biofluids, tissues or organisms. Together, these ...
(Date:5/3/2016)... Francisco, CA (PRWEB) , ... May 03, 2016 ... ... Morf Playbook™ enterprise talent development, skill-building and compliance training platform on mobile ... training course: Overview of Regulatory Requirements for Medical Devices. The course is ...
(Date:5/3/2016)... ... May 03, 2016 , ... Kerafast Inc., developers ... from laboratories across the globe, today announced the availability of a Zika virus ... research toward treatment and prevention measures for the Zika virus, the virus’s geographical ...
(Date:5/3/2016)... ... 2016 , ... According to world renowned prostate cancer surgeon, Dr. David ... had two main treatment options: surgery or radiation. Based on a patient’s goals, disease ... has enabled doctors to administer higher doses of radiation to prostate cancer ...
Breaking Biology Technology:
(Date:3/14/2016)... 2016 NXTD ) ("NXT-ID" or the ... announces the airing of a new series of commercials on ... March 21 st .  The commercials will air on Bloomberg ... on the Street show. --> NXTD ) ("NXT-ID" ... commerce market, announces the airing of a new series of ...
(Date:3/11/2016)... http://www.apimages.com ) - --> http://www.apimages.com ... at AP Images ( http://www.apimages.com ) - Germany ... produce the new refugee identity cards. DERMALOG will be unveiling this ... Hanover next week.   --> ... to produce the new refugee identity cards. DERMALOG will be unveiling ...
(Date:3/10/2016)... , March 10, 2016 ... market research report "Identity and Access Management Market by ... Compliance, and Governance), by Organization Size, by Deployment, by ... published by MarketsandMarkets, The market is estimated to grow ... Billion by 2020, at a Compound Annual Growth Rate ...
Breaking Biology News(10 mins):